Yahoo Web Search

Search results

  1. en.m.wikipedia.org › wiki › Andrew_ConradAndrew Conrad - Wikipedia

    Andrew J. Conrad is an American geneticist who heads Verily, a life sciences division of Alphabet Inc. As its chief executive officer, Conrad has recruited a multidisciplinary team of chemists, doctors, engineers, behavioral scientists and data scientists to research health and disease.

  2. Andy Conrad Having recently led groundbreaking work in the field of diagnostics as a molecular biologist and Chief Scientist at LabCorp, Andy joined the Google X team with the audacious goal to deliver a “10x change” in healthcare.

  3. Andrew Conrad, PhD, is the Chief Executive Officer, Chairman and Founder of Verily where he oversees an integrated team of engineers, scientists, designers, ...

  4. Explore Verily leadership, executive profiles, and advisory board.

  5. Andy Conrad is the Head of Google Life Sciences where he oversees more than 150 scientists working on a wide spectrum of healthcare related projects. Previously, he was Chief Scientific Officer of Laboratory Corporation of America (LabCorp).

  6. Aug 25, 2020 · But Verily CEO Andrew Conrad is reportedly divisive within the company and impulsive about what projects Verily takes on. And it’s been unclear how Verily would make money, despite its lofty...

  7. Mar 28, 2016 · Some former employees of Google's Verily blame its CEO Andrew Conrad for an exodus of the firm's top talent. Bethany Izard for STAT. M OUNTAIN VIEW, Calif. — Google’s brash attempt to...

  8. Dec 22, 2021 · The added responsibilities will see Gillett work alongside the founder and CEO of Verily, Andy Conrad, as well as the rest of the executive team, to guide the Alphabet offshoot through its...

  9. Andrew Conrad, PhD, is the Chief Executive Officer, Chairman and Founder of Verily where he oversees an integrated team of engineers, scientists, designers, and medical experts working on a wide spectrum of healthcare-related projects.

  10. Dec 21, 2021 · Verily CEO Andy Conrad is taking a longer-term, more strategic role at the Alphabet life sciences company and is promoting chief operating officer Stephen Gillett to president and COO.

  1. People also search for